Dimer Pharmaceuticals is transforming cancer and neurodegenerative disease treatment. Focused on pediatric high-risk neural tumors, we develop novel therapies for underserved patients. Our breakthroughs in shared biological pathways, prion biology, and advanced cancer strategies target the molecular mechanisms driving highly resistant cancers and neurodegeneration, redefining care and delivering life-changing outcomes worldwide.